Fudan-Zhangjiang Clarifies 20 May 2026 Deadline for H-Share Transfer Ahead of AGM

Bulletin Express
Apr 29

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. issued a clarification confirming that holders of its H Shares must lodge transfer documents with the Company’s H-share registrar by 4:30 p.m. on Wednesday, 20 May 2026 in order to qualify for attendance and voting rights at the upcoming Annual General Meeting (AGM).

The updated cut-off supersedes the timing previously stated on page 9 and page AGM-4 of the circular dated 29 April 2026 as well as page 4 of the AGM notice. All remaining information in both documents remains unchanged.

Board composition at the date of the announcement is as follows: • Executive Directors: Zhao Da Jun (Chairman), Xue Yan • Non-executive Directors: Shen Bo, Yu Xiao Yang • Independent Non-executive Directors: Wang Hong Guang, Lam Siu Wing, Xu Pei Long • Employee Director: Qu Ya Nan

The clarification is intended to ensure shareholders adhere to the correct administrative deadline for AGM participation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10